20/20 GeneSystems on StartEngine | Deal Review

Apr 27, 2021 1 min read
20/20 GeneSystems, Inc.
Diagnostic Testing for COVID-19 & Cancer

20/20 GeneSystems Campaign's Highlights

Diagnostic Testing for COVID-19 & Cancer
  • Huge Market - The global cancer diagnostics market was valued at $7.1 billion in 2015 and is projected to reach $13.1 billion by the year 2020
  • Experienced Team - Our CEO previously established strategic partnerships with Fortune 500 companies such as Johnson & Johnson, Eastman Kodak, Abbott Diagnostics and Smiths Detection
  • Traction - We're backed by China’s Ping An Ventures, likely the world’s largest Healthcare AI company (300 million users of its mobile diagnostic app) & thousands of investors

Did I Invest In 20/20 GeneSystems?

I’m still in the process of writing a full deal report and decide whether or not I will invest in 20/20 GeneSystems. I review 100+ startups on 10+ platforms every month and send a detailed report every Saturday to subscribers of the Angel Notes newsletter (you can join through the form below). See you soon!

Great! Next, complete checkout for full access to Angel Notes.
Welcome back! You've successfully signed in.
You've successfully subscribed to Angel Notes.
Success! Your account is fully activated, you now have access to all content.
Success! Your billing info has been updated.
Your billing was not updated.